Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 09/28 12:30:47 pm
68.56 EUR   +0.91%
09/27 SANOFI : BARDA Grants $ 43.2 million USD to Sanofi Pasteur for Zika?
09/27 FDA GRANTS PRIO : REGN), Sanofi SA (NYSE:SNY)
09/27 SANOFI : (SNY) Receives $43.2M BARDA Grant for Zika Vaccine Developm..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CEST

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
09/27 SANOFI : BARDA Grants $ 43.2 million USD to Sanofi Pasteur for Zika?
09/27 FDA GRANTS PRIORITY REVIEW FOR DUPIL : REGN), Sanofi SA (NYSE:SNY)
09/27 SANOFI : (SNY) Receives $43.2M BARDA Grant for Zika Vaccine Development
09/27 SANOFI : AHN doctors, patients to have role in diabetic device development
09/26DJLufthansa Hits Limits of ECB Bond Buying
09/26 SANOFI : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika ​
09/26 SANOFI : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/26 SANOFI : and Regeneron Announce Dupilumab Biologics License Application Accepted..
09/26 SANOFI : Regeneron and Sanofi Announce Dupilumab Biologics License Application A..
More news
Sector news : Pharmaceuticals - NEC
12:00p Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09/27 Novo Shows Its Devotion To Tresiba's Cause
09/26 FDA accepts dupilumab BLA for review; action date March 29, 2017
09/26 MANNKIND : Afrezza Scripts Approach 300; Trajectory Is Still Low
09/26 Amgen's New Products Have Ample Insurance Coverage In The U.S.
09/24 BIOTECH : What's Next For M&A?
Advertisement
Financials (€)
Sales 2016 36 859 M
EBIT 2016 9 283 M
Net income 2016 5 275 M
Debt 2016 5 441 M
Yield 2016 4,32%
P/E ratio 2016 15,58
P/E ratio 2017 14,28
EV / Sales 2016 2,52x
EV / Sales 2017 2,53x
Capitalization 87 578 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 82,5 €
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
JÚr˘me Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-13.56%97 974
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results